Skip to main content

Day: September 20, 2024

Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed

Bagsværd, Denmark, 20 September 2024 – Novo Nordisk today announced headline results from a phase 2a clinical trial with monlunabant, a small molecule oral cannabinoid receptor 1 (CB1) inverse agonist. Monlunabant, formerly INV-202, was part of the acquisition of Inversago Pharmaceuticals Inc. announced in August 2023 [Link]. The trial investigated the efficacy and safety of a once-daily 10 mg, 20 mg and 50 mg dose of monlunabant compared to placebo on body weight after 16 weeks in 243 people with obesity and metabolic syndrome1. People were equally randomised among the four treatment arms. From a baseline body weight of 110.1 kg, all doses of monlunabant achieved a statistically significant weight loss compared to placebo. After 16 weeks of treatment, people treated with a once-daily 10 mg dose of monlunabant achieved a weight loss of...

Continue reading

SEALSQ Integrates Internet of Payment (IoP) in Next-Generation IoT-Enabled Semiconductors, Revolutionizing Connected Commerce

Geneva, Switzerland, Sept. 20, 2024 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products, today announced the integration of Internet of Payment (IoP) capabilities into its next-generation IoT-enabled semiconductor solutions. This bold step positions SEALSQ at the forefront of a digital revolution, where connected devices transcend their traditional roles, morphing into dynamic commercial hubs capable of secure and autonomous transactions. IoP: Ushering in a New Era of Commerce The Internet of Things (IoT) has transformed everyday objects into smart, connected devices capable of communication and data exchange. Now, with the IoP integration, SEALSQ is taking this...

Continue reading

Diagnostic Imaging Market Forecast to Grow at 5.4% CAGR from 2024 to 2031 | SkyQuest Technology

Westford, USA, Sept. 20, 2024 (GLOBE NEWSWIRE) — Diagnostic Imaging Market Forecast to Grow at 5.4% CAGR from 2024 to 2031 | SkyQuest Technology  SkyQuest projects that the Global Diagnostic Imaging Market will reach a value of USD 42167.31 Million by 2031, with a CAGR of 5.4% during the forecast period (2024-2031).  It is projected that the growing elderly population, coupled with the rising incidence of chronic diseases and the need for early disease diagnosis and detection techniques, will propel market expansion. Due to rising investments by large players, new product innovations, and advancements in technology such as portable medical devices for diagnosis at patients’ places of residence or using AI-based approach for image processing techniques in radiology, the market is expected to experience more development. Get a Free...

Continue reading

M3-Brigade Acquisition V Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing September 23, 2024

NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) — M3-Brigade Acquisition V Corp. (the “Company”) announced that, commencing on September 23, 2024, holders of the units sold in the Company’s initial public offering of 28,750,000 units, which includes 3,750,000 units issued pursuant to the exercise by the underwriters of their overallotment option, completed on August 2, 2024 may elect to separately trade the Class A ordinary shares and warrants included in the units. Class A ordinary shares and warrants that are separated will trade on the Nasdaq Global Market under the symbols “MBAV” and “MBAVW,” respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “MBAVU.” No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of the units...

Continue reading

MEDIA AVAILABILITY: CN Police Officers Available For Media Interviews During See Tracks? Think Train Week

Be Rail Smart on or around rail property and help prevent accidents and injuries at rail crossings Help share the message during See Tracks? Think Train Week (Sept. 23-29)HOMEWOOD, Ill., Sept. 20, 2024 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) will offer members of the media the opportunity to talk with CN police officers in uniform during See Tracks? Think Train Week, an annual public awareness campaign that runs from September 23-29. Throughout the week, CN officers will travel across the country and into communities to participate in safety initiatives at commuter and railway crossings, share rail safety tips and to highlight the dangers of trespassing on railway tracks and property. CN invites media outlets to contact our regional media contacts to arrange onsite, in-studio or on-air interviews. The CN media relations...

Continue reading

Arq, Inc. Announces Pricing of $25 Million Public Offering of Common Stock

GREENWOOD VILLAGE, Colo., Sept. 20, 2024 (GLOBE NEWSWIRE) — Arq, Inc. (NASDAQ: ARQ) (“Arq” or the “Company”), a producer of activated carbon and other environmentally efficient carbon products for use in purification and sustainable materials, today announced the pricing of an underwritten public offering of 4,770,000 shares of its common stock, par value $0.001 per share (“common stock”), at a price to the public of $5.25 per share. All of the shares in the offering are being sold by Arq. The gross proceeds to Arq from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be approximately $25 million. The offering is expected to close on or about September 23, 2024, subject to customary closing conditions. In addition, Arq has granted the underwriters a 30-day option...

Continue reading

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and older Data demonstrate that the Omicron KP.2-adapted COVID-19 vaccine generates a substantially improved response against multiple circulating Omicron JN.1 sublineages as did the Omicron JN.1-adapted COVID-19 vaccine authorized by the European Commission in July 2024 Doses will be ready to ship to applicable European Union member states as soon as possible upon European Commission authorizationNEW YORK and MAINZ, GERMANY, SEPTEMBER 20, 2024 — Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency (“EMA”) has recommended marketing authorization for the companies’...

Continue reading

Canacol Energy Ltd. Announces Revised 2024 Capital Program, Comments on 2024 Guidance and Provides Drilling Update

CALGARY, Alberta, Sept. 20, 2024 (GLOBE NEWSWIRE) — Canacol Energy Ltd. (“Canacol” or the “Corporation”) (TSX: CNE; OTCQX: CNNEF; BVC: CNEC) announces that it has revised its 2024 capital program, comments on 2024 guidance and provides drilling update. Revised 2024 Capital Program The Corporation has revised its capital program to now drill a total of 11 wells in 2024, with an estimated capital spend of $138 million. The 11-well program includes five exploration wells, and six development/appraisal wells. Canacol’s original 2024 capital budget, as announced on February 5, 2024, had included a range of $138 million (four exploration wells and three development/appraisal wells) to $151 million (four exploration wells and five development/appraisal wells). Drilling program efficiency initiatives have contributed significantly to planning...

Continue reading

Nano Dimension and HENSOLDT AG Announce: Expanding Investment in their Joint Venture – J.A.M.E.S – For Advancement of 3D Printed Electronics Industry

The JV, Established in July 2021, Gets Renewal From Respective Partners Given Success in Increasing Adoption of Additively Manufactured Electronics Technology Waltham, Mass., Sept. 20, 2024 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension” or the “Company”), a leading supplier of Additively Manufactured Electronics (“AME”) and multi-dimensional polymer, metal & ceramic Additive Manufacturing (“AM”) 3D printing solutions, along with HENSOLDT AG (“HENSOLDT”), today announced their respective leadership teams have agreed to continue the joint venture Jetted Additively Manufactured Electronics Sources GmbH (“J.A.M.E.S”). J.A.M.E.S, based in Taufkirchen, Germany, combines the strengths of both Nano Dimension and HENSOLDT to advance the development of 3D printed electronics. J.A.M.E.S established itself as...

Continue reading

How to write the perfect AI prompt: iStock’s 10 step guide to transform ideas into stunning images

For the right project, AI-generated content offers SMBs and SMEs a way to unlock creative potential, streamline marketing efforts, and create time efficiencies. However, the ability to craft effective prompts—concise, creative instructions for AI tools—is emerging as a key advantage for businesses looking to leverage AI for their visual content. While AI generated images have opened new possibilities to create unique visuals, the difference between good and great often comes down to the tool but also – the prompt. To unlock these benefits, iStock experts share a 10-step guide to help anyone build compelling prompts and get the most out of text-to-image generative AI tools.  A Media Snippet accompanying this announcement is available by clicking on this link. NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) — As text...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.